Mavericc: A randomized phase II study of Bevacizumab/mFolfox6 vs. Bevacizumab/FOLFIRI with biomarker stratification in patients with previously untreated metastatic colorectal cancer

Project: Research project

Status	Finished
Effective start/end date	1/1/11 → 1/1/15

Project Details